Dry Eye Mask for Soothing Comfort and Circulation
Heat
The use of heat is a well-established and important adjunct therapy in the management of meibomian gland dysfunction. As an Eye Care Professional your challenge is to deliver this therapy to your patients effectively and safely.
iFlo™ USB Heating Eye Compress gives you this reassurance and convenience to your patients, now enhanced with recycled fabric, incorporating 3M Thinsulate material, to provide gentle and effective heat therapy.
iFlo™ USB Heating Eye Compress
iFlo™ USB Heating Eye Compress is a smart eye mask designed to provide heating comfort to the eyes, with a new, more sustainable design. It can relieve eye fatigue and discomfort caused by dry eye or other eye problems. It can also accelerate the blood circulation around the eye to improve black eye circle conditions. There is a removable sheet on the eye mask for the user to clean and keep hygiene.
Benefits of
iFlo™ USB Heating Eye Compress
Made with Recycled Fabric
Features a soft-touch feel with recycled fabric
Eye relief
Relieves eye fatigue and discomfort, including dry eye and MGD.
Smart design for heating and comfort
It works by using the USB cable, connected to a power bank, computer, or any other power source to heat the mask for 12 minutes before automatically turning off.
Improved eye circulation
Enhances blood circulation, targeting black eye circle conditions.
Discover the
Heated Eye Wand™ LED+
Designed to provide targeted and controlled heat, massage, and red LED therapy to address the underlying causes of evaporative dry eye and improve patient comfort.
Interested in using iFlo™ USB Heating Eye Compress in your practice?
Contact us to find out more about iFlo™ USB Heating Eye Compress and to order.
Read the news on
Positive Impact
Positive Impact (PI) confirms that its exclusive partnership with CSI Innovations (CSI) formerly known as CSI Dry Eye Software, has ended under a revised UK distribution structure for the Canadian software brand.
The opticians’ favourite lens cleaning system is now more accessible than ever. We’ve removed the barrier of initial capital investment so you can focus on patient loyalty and practice growth.
Positive Impact (PI) will be showing its independent-only portfolio and launching two new diagnostic instruments.
This will be the debut for the return of the Keratron topographer range to the UK.
References
* Data was collected from a population of 22 eyes (age 18-89) of any race, gender or ethnicity, diagnosed with meibomian gland
dysfunction. Additional inclusion/exclusion criteria were applied. More information can be found at ClinicalTrials.gov